Healthcare Experience


Our Healthcare experience includes 812 clients, with 73 partnered brands and 759 USAN/INN names. Below is our extensive portfolio, feel free to filter by clients, brands, category or USAN/INN Names.   ||  Click Here for Consumer/B2B Experience



CLIENTS BRANDS CATEGORY
ORION PHARMA tasipimidine Animal Health
OTSUKA PHARMACEUTICAL DELTYBA Antibiotic
ORION PHARMA ARAMIS (ANDROGEN RECEPTOR INHIBITING AGENT FOR METASTATIC-FREE SURVIVAL Clinical Trial Name
OSI PHARMACEUTICALS GALACCTIC Clinical Trial Name
OPEXA THERAPEUTICS ABILI-T Clinical Trial Name
ORTHOSENSOR ORTHOSENSOR Corporate Identity
ONCOLOGY THERAPEUTICS NETWORK OTN - ONCOLOGY THERAPEUTICS NETWORK Corporate Identity
OBAGI MEDICAL SOLUCLENZ Dermatology
OBAGI MEDICAL CLENZIDERM M.D. Dermatology
ORTHO-MCNEIL PHARMACEUTICAL PANCREAZE Gastrointestinal
OCERA THERAPEUTICS ZYSA Gastrointestinal
OCTAPHARMA AB NUWIQ * Hematology
OCTAPHARMA AB VIHUMA Hematology
OCTAPHARMA AB FIBRYNA * Hematology
Oscotec cevidoplenib Immunology
OCTAPHARMA CUTAQUIG Immunology
OBI PHARMA adagloxad simolenin Immunology
OCTAPHARMA AB PANZYGA * Immunology
OPEXA THERAPEUTICS imilecleucel-t Immunology
ONO ceralifimod immunology
OTICON ALTA Medical Device
OTICON NERA Medical Device
ORTHOSENSOR VERASENSE Medical Device
OSSUR SYMBIONIC LEG Medical Device
ORTHO DERMATOLOGICS RETIN-A MICRO PUMP Medical Device
OTSUKA PHARMACEUTICAL ORALTAG * Medical Device
OTTOBOCK AGILIUM FREESTEP Medical Device
OTSUKA PHARMACEUTICAL JINARC * Nephrology
OPKO HEALTH RAYALDEE * Nephrology
OTSUKA PHARMACEUTICAL tolvaptan Nephrology
OTSUKA PHARMACEUTICAL JYNARQUE * Nephrology
ORTHO-MCNEIL PHARMACEUTICAL RAZADYNE Neurology
ORTHO-MCNEIL PHARMACEUTICAL RAZADYNE ER Neurology
ORTHO-MCNEIL PHARMACEUTICAL TOPAMAX Neurology
OVATION PHARMACEUTICALS SABRIL * Neurology
OTSUKA PHARMACEUTICAL brexpiprazole Neurology
OREXO AB ZUBSOLV * Neurology
ORION PHARMA COMTAN * Neurology
OSMOTICA PHARMACEUTICAL OSMOLEX ER Neurology
ORION PHARMA neluxicapone Neurology
OTSUKA PHARMACEUTICAL ABILIFY MAINTENA * Neurology
OTSUKA PHARMACEUTICAL REXULTI * Neurology
OWP PHARMACEUTICALS ROWEEPRA Neurology
OREXIGEN THERAPEUTICS CONTRAVE * Obesity
ONCOMED brontictuzumab Oncology
OCTREOPHARM satoreotide trizoxetan Oncology
ONCOMED navicixizumab Oncology
ONCOTHERAPYSCIENCE tabituximab Oncology
ONCOTHERAPYSCIENCE tabituximab barzuxetan Oncology
Onxeo etidaligide Oncology
OncoMed etigilimab Oncology
OncoSec tavokinogene telseplasmid Oncology
ONCOMED rosmantuzumab Oncology
OCTAPHARMA AB satoreotide Oncology
ONCOMED navicixizumab Oncology
ONCOMED vantictumab Oncology
ONCOMED ipafricept Oncology
ONCOMED tarextumab Oncology
ONCOMED demcizumab Oncology
ONCOTHERAPY SCIENCE latromotide Oncology
ONCOTHERAPY SCIENCE pradimotide Oncology
OXIGENE fosbretabulin Oncology
OXIGENE fosbretabulin disodium Oncology
OXIGENE fosbretabulin tromethamine Oncology
OSI PHARMACEUTICALS TARCEVA * Oncology
ONCOPEPTIDES melphalan flufenamide Oncology
ONCOTHERAPY SCIENCE elpamotide Oncology
OSI PHARMACEUTICALS linsitinib Oncology
OTSUKA PHARMACEUTICAL MIKELUNA Ophthalmology
OLATEC dapansutrile Pain & Inflammation
ORTHO-MCNEIL PHARMACEUTICAL DURAGESIC Pain & Inflammation
OSMOTICA PHARMACEUTICAL VENALTA - Product Identity
OPTINOSE XHANCE * Respiratory
OPEXA THERAPEUTICS IMMPATH Technology Name


* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

Back to top